1. Home
  2. CORT vs WAL Comparison

CORT vs WAL Comparison

Compare CORT & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$114.47

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$82.32

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
WAL
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.8B
IPO Year
2001
2005

Fundamental Metrics

Financial Performance
Metric
CORT
WAL
Price
$114.47
$82.32
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$96.50
$91.69
AVG Volume (30 Days)
1.2M
732.7K
Earning Date
04-30-2026
04-21-2026
Dividend Yield
N/A
2.11%
EPS Growth
N/A
23.13
EPS
0.09
3.99
Revenue
$761,407,000.00
$135,800,000.00
Revenue This Year
$26.08
$20.49
Revenue Next Year
$26.98
$8.08
P/E Ratio
$1,228.89
$20.50
Revenue Growth
12.79
99.71
52 Week Low
$28.66
$65.82
52 Week High
$122.21
$97.23

Technical Indicators

Market Signals
Indicator
CORT
WAL
Relative Strength Index (RSI) 64.64 51.78
Support Level $76.41 $77.75
Resistance Level $122.21 $84.93
Average True Range (ATR) 5.13 1.82
MACD -0.09 -0.07
Stochastic Oscillator 75.23 43.37

Price Performance

Historical Comparison
CORT
WAL

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: